Enveric Biosciences Inc. (ENVB)
$1.37
$0.00 (0.00%)As on 27-Aug-2026 16:00EDT
Market cap
$6 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.7 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.3
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-9.9
-
Face value
--
-
Shares outstanding
4,475,884
10 Years Aggregate
CFO
$-60.77 Mln
EBITDA
$-84.17 Mln
Net Profit
$-127.43 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Enveric Biosciences (ENVB)
| -62.3 | 6.2 | -38.6 | -91.4 | -84.8 | -84.6 | -78.3 |
|
BSE Sensex*
| -9.0 | 0.3 | 1.5 | -4.6 | 5.9 | 6.5 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Enveric Biosciences (ENVB)
| -94.4 | -72.1 | -37.5 | -95.5 | -78.2 | -52.9 | -48.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Enveric Biosciences (ENVB)
|
1.4 | 6.4 | 0.0 | -8.7 | -- | -142.4 | -- | 0.8 |
| 88.6 | 12,304.7 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.4 | |
| 249.4 | 16,614.0 | 1,054.4 | 755.9 | 5.7 | -- | 19.4 | 10.1 | |
| 77.9 | 10,682.6 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 55.3 | 13,400.0 | 2,435.9 | 860.6 | 31.0 | 43 | 17 | 7.3 | |
| 106.9 | 12,277.1 | 1,663.7 | 413.6 | 36.3 | 430 | 31.2 | 83.9 | |
| 543.7 | 11,938.8 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 22.9 | |
| 611.6 | 17,326.2 | 2,782.3 | 491.5 | 21.1 | 110.1 | 36.5 | 39.4 | |
| 367.9 | 10,496.2 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 | |
| 149.5 | 9,985.8 | 282.0 | 82.9 | -28.6 | 11.4 | 147 | 11.6 |
Shareholding Pattern
View DetailsAbout Enveric Biosciences (ENVB)
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003,... a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts. Read more
-
CEO & Director
Dr. Joseph Edward Tucker Ph.D.
-
CEO & Director
Dr. Joseph Edward Tucker Ph.D.
-
Headquarters
Cambridge, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Enveric Biosciences (ENVB)
What is the current share price of Enveric Biosciences Inc (ENVB) Today?
The share price of Enveric Biosciences Inc (ENVB) is $1.37 (NASDAQ) as of 27-Aug-2026 16:00 EDT. Enveric Biosciences Inc (ENVB) has given a return of -84.78% in the last 3 years.
What is the current PB & PE ratio of Enveric Biosciences Inc (ENVB)?
Since, TTM earnings of Enveric Biosciences Inc (ENVB) is negative, P/E ratio is not available.
The P/B ratio of Enveric Biosciences Inc (ENVB) is 0.77 times as on 21-Aug-2026, a 86 discount to its peers’ median range of 5.35 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.32 |
0.92 |
2024 |
0.00 |
0.01 |
2023 |
-7.71 |
0.07 |
2022 |
-0.01 |
0.01 |
2021 |
0.00 |
0.00 |
What is the 52 Week High and Low of Enveric Biosciences Inc (ENVB)?
The 52-week high and low of Enveric Biosciences Inc (ENVB) are Rs 17.64 and Rs 1.17 as of 28-Aug-2026.
What is the market cap of Enveric Biosciences Inc (ENVB)?
Enveric Biosciences Inc (ENVB) has a market capitalisation of $ 6 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Enveric Biosciences Inc (ENVB)?
Before investing in Enveric Biosciences Inc (ENVB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.